Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 143 entries
Sorted by: Best Match Show Resources per page
Genome Sequences of Newly Isolated Mycobacteriophages Forming Cluster S.

Genome announcements

Mills ML, Bragg J, Bruce A, Dehn A, Drouin J, Hefner M, Katon D, McHugh D, Zeba F, Bowman CA, Cresawn SG, Jacobs-Sera D, Russell DA, Pope WH, Hatfull GF, Dunbar DA, Zegers GP, Page ST.
PMID: 27688332
Genome Announc. 2016 Sep 29;4(5). doi: 10.1128/genomeA.00933-16.

We describe the genomes of two mycobacteriophages, MosMoris and Gattaca, newly isolated on Mycobacterium smegmatis The two phages are very similar to each other, differing in 61 single nucleotide polymorphisms and six small insertion/deletions. Both have extensive nucleotide sequence...

Cite
Mills ML, Bragg J, Bruce A, et al. Genome Sequences of Newly Isolated Mycobacteriophages Forming Cluster S. Genome Announc. 2016;4(5)doi: 10.1128/genomeA.00933-16.
Mills, M. L., Bragg, J., Bruce, A., Dehn, A., Drouin, J., Hefner, M., Katon, D., McHugh, D., Zeba, F., Bowman, C. A., Cresawn, S. G., Jacobs-Sera, D., Russell, D. A., Pope, W. H., Hatfull, G. F., Dunbar, D. A., Zegers, G. P., & Page, S. T. (2016). Genome Sequences of Newly Isolated Mycobacteriophages Forming Cluster S. Genome announcements, 4(5), . https://doi.org/10.1128/genomeA.00933-16
Mills, Monique L, et al. "Genome Sequences of Newly Isolated Mycobacteriophages Forming Cluster S." Genome announcements vol. 4,5 (2016). doi: https://doi.org/10.1128/genomeA.00933-16
Mills ML, Bragg J, Bruce A, Dehn A, Drouin J, Hefner M, Katon D, McHugh D, Zeba F, Bowman CA, Cresawn SG, Jacobs-Sera D, Russell DA, Pope WH, Hatfull GF, Dunbar DA, Zegers GP, Page ST. Genome Sequences of Newly Isolated Mycobacteriophages Forming Cluster S. Genome Announc. 2016 Sep 29;4(5). doi: 10.1128/genomeA.00933-16. PMID: 27688332; PMCID: PMC5043550.
Copy Download .nbib Format: NLM
The medical bookshelf.

Postgraduate medicine

Bluestone R, Ryan AJ, Shoch D, Howard RB, Barnes RW, Mayberg DM, Petersen DA, Sharpe IK, Plerach CA, Cassady G.
PMID: 27438949
Postgrad Med. 1977 Nov;62(5):53-57. doi: 10.1080/00325481.1977.11714670.

No abstract available.

Cite
Bluestone R, Ryan AJ, Shoch D, et al. The medical bookshelf. Postgrad Med. 1977;62(5):53-57doi: 10.1080/00325481.1977.11714670.
Bluestone, R., Ryan, A. J., Shoch, D., Howard, R. B., Barnes, R. W., Mayberg, D. M., Petersen, D. A., Sharpe, I. K., Plerach, C. A., & Cassady, G. (1977). The medical bookshelf. Postgraduate medicine, 62(5), 53-57. https://doi.org/10.1080/00325481.1977.11714670
Bluestone, Rodney, et al. "The medical bookshelf." Postgraduate medicine vol. 62,5 (1977): 53-57. doi: https://doi.org/10.1080/00325481.1977.11714670
Bluestone R, Ryan AJ, Shoch D, Howard RB, Barnes RW, Mayberg DM, Petersen DA, Sharpe IK, Plerach CA, Cassady G. The medical bookshelf. Postgrad Med. 1977 Nov;62(5):53-57. doi: 10.1080/00325481.1977.11714670. PMID: 27438949.
Copy Download .nbib Format: NLM
Combination of Photon and Carbon Ion Irradiation with Targeted Therapy Substances Temsirolimus and Gemcitabine in Hepatocellular Carcinoma Cell Lines.

Frontiers in oncology

Dehne S, Fritz C, Rieken S, Baris D, Brons S, Haberer T, Debus J, Weber KJ, Schmid TE, Combs SE, Habermehl D.
PMID: 28348976
Front Oncol. 2017 Mar 13;7:35. doi: 10.3389/fonc.2017.00035. eCollection 2017.

BACKGROUND: This work investigates on putative cytotoxic effects in four different hepatocellular carcinoma (HCC) cell lines after irradiation with photons or carbon ions in combination with new targeted molecular therapy using either Temsirolimus (TEM) or Gemcitabine (GEM).METHODS AND MATERIALS:...

Cite
Dehne S, Fritz C, Rieken S, et al. Combination of Photon and Carbon Ion Irradiation with Targeted Therapy Substances Temsirolimus and Gemcitabine in Hepatocellular Carcinoma Cell Lines. Front Oncol. 2017;7:35doi: 10.3389/fonc.2017.00035.
Dehne, S., Fritz, C., Rieken, S., Baris, D., Brons, S., Haberer, T., Debus, J., Weber, K. J., Schmid, T. E., Combs, S. E., & Habermehl, D. (2017). Combination of Photon and Carbon Ion Irradiation with Targeted Therapy Substances Temsirolimus and Gemcitabine in Hepatocellular Carcinoma Cell Lines. Frontiers in oncology, 735. https://doi.org/10.3389/fonc.2017.00035
Dehne, Sarah, et al. "Combination of Photon and Carbon Ion Irradiation with Targeted Therapy Substances Temsirolimus and Gemcitabine in Hepatocellular Carcinoma Cell Lines." Frontiers in oncology vol. 7 (2017): 35. doi: https://doi.org/10.3389/fonc.2017.00035
Dehne S, Fritz C, Rieken S, Baris D, Brons S, Haberer T, Debus J, Weber KJ, Schmid TE, Combs SE, Habermehl D. Combination of Photon and Carbon Ion Irradiation with Targeted Therapy Substances Temsirolimus and Gemcitabine in Hepatocellular Carcinoma Cell Lines. Front Oncol. 2017 Mar 13;7:35. doi: 10.3389/fonc.2017.00035. eCollection 2017. PMID: 28348976; PMCID: PMC5346564.
Copy Download .nbib Format: NLM
Bridging the gap between systems biology and medicine.

Genome medicine

Clermont G, Auffray C, Moreau Y, Rocke DM, Dalevi D, Dubhashi D, Marshall DR, Raasch P, Dehne F, Provero P, Tegner J, Aronow BJ, Langston MA, Benson M.
PMID: 19754960
Genome Med. 2009 Sep 29;1(9):88. doi: 10.1186/gm88.

Systems biology has matured considerably as a discipline over the last decade, yet some of the key challenges separating current research efforts in systems biology and clinically useful results are only now becoming apparent. As these gaps are better...

Cite
Clermont G, Auffray C, Moreau Y, et al. Bridging the gap between systems biology and medicine. Genome Med. 2009;1(9):88doi: 10.1186/gm88.
Clermont, G., Auffray, C., Moreau, Y., Rocke, D. M., Dalevi, D., Dubhashi, D., Marshall, D. R., Raasch, P., Dehne, F., Provero, P., Tegner, J., Aronow, B. J., Langston, M. A., & Benson, M. (2009). Bridging the gap between systems biology and medicine. Genome medicine, 1(9), 88. https://doi.org/10.1186/gm88
Clermont, Gilles, et al. "Bridging the gap between systems biology and medicine." Genome medicine vol. 1,9 (2009): 88. doi: https://doi.org/10.1186/gm88
Clermont G, Auffray C, Moreau Y, Rocke DM, Dalevi D, Dubhashi D, Marshall DR, Raasch P, Dehne F, Provero P, Tegner J, Aronow BJ, Langston MA, Benson M. Bridging the gap between systems biology and medicine. Genome Med. 2009 Sep 29;1(9):88. doi: 10.1186/gm88. PMID: 19754960; PMCID: PMC2768995.
Copy Download .nbib Format: NLM
WITHDRAWN: Characteristic markers of the WNT signalling pathway are differentially expressed in osteoarthritic cartilage.

Osteoarthritis and cartilage

Thorfve A, Dehne T, Lindahl A, Brittberg M, Pruss A, Ringe J, Sittinger M, Karlsson C.
PMID: 20433935
Osteoarthritis Cartilage. 2010 Apr 28; doi: 10.1016/j.joca.2010.03.009. Epub 2010 Apr 28.

No abstract available.

Cite
Thorfve A, Dehne T, Lindahl A, et al. WITHDRAWN: Characteristic markers of the WNT signalling pathway are differentially expressed in osteoarthritic cartilage. Osteoarthritis Cartilage. 2010;doi: 10.1016/j.joca.2010.03.009.
Thorfve, A., Dehne, T., Lindahl, A., Brittberg, M., Pruss, A., Ringe, J., Sittinger, M., & Karlsson, C. (2010). WITHDRAWN: Characteristic markers of the WNT signalling pathway are differentially expressed in osteoarthritic cartilage. Osteoarthritis and cartilage, . https://doi.org/10.1016/j.joca.2010.03.009
Thorfve, A, et al. "WITHDRAWN: Characteristic markers of the WNT signalling pathway are differentially expressed in osteoarthritic cartilage." Osteoarthritis and cartilage vol. (2010). doi: https://doi.org/10.1016/j.joca.2010.03.009
Thorfve A, Dehne T, Lindahl A, Brittberg M, Pruss A, Ringe J, Sittinger M, Karlsson C. WITHDRAWN: Characteristic markers of the WNT signalling pathway are differentially expressed in osteoarthritic cartilage. Osteoarthritis Cartilage. 2010 Apr 28; doi: 10.1016/j.joca.2010.03.009. Epub 2010 Apr 28. PMID: 20433935.
Copy Download .nbib Format: NLM
Fractional flow reserve (FFR): changing the practice of interventional cardiology.

Minerva cardioangiologica

Kaluski E, Waller AH, Rudzinski W, Nasur A, Dehnee A, Gerula C, Maher J, Dhruvakumar S, Mazza V.
PMID: 23018433
Minerva Cardioangiol. 2012 Oct;60(5):539-48.

Fractional flow reserve (FFR) has become an extremely valuable tool for assessing the hemodynamic significance of intermediate coronary lesions. This manuscript delineates the current guidelines regarding the use of FFR and discusses emerging indications for the use of this...

Cite
Kaluski E, Waller AH, Rudzinski W, et al. Fractional flow reserve (FFR): changing the practice of interventional cardiology. Minerva Cardioangiol. 2012;60(5):539-48
Kaluski, E., Waller, A. H., Rudzinski, W., Nasur, A., Dehnee, A., Gerula, C., Maher, J., Dhruvakumar, S., & Mazza, V. (2012). Fractional flow reserve (FFR): changing the practice of interventional cardiology. Minerva cardioangiologica, 60(5), 539-48.
Kaluski, E, et al. "Fractional flow reserve (FFR): changing the practice of interventional cardiology." Minerva cardioangiologica vol. 60,5 (2012): 539-48.
Kaluski E, Waller AH, Rudzinski W, Nasur A, Dehnee A, Gerula C, Maher J, Dhruvakumar S, Mazza V. Fractional flow reserve (FFR): changing the practice of interventional cardiology. Minerva Cardioangiol. 2012 Oct;60(5):539-48. PMID: 23018433.
Copy Download .nbib Format: NLM
Does anyone need help? Age and gender effects on children's ability to recognize need-of-help.

Frontiers in psychology

Stolarova M, Brielmann AA.
PMID: 24578698
Front Psychol. 2014 Feb 27;5:170. doi: 10.3389/fpsyg.2014.00170. eCollection 2014.

The exploratory study presented here examines children's ability to recognize another person's need-of-help. This social perception process necessarily precedes the decision to actively help others. Fifty-eight children aged between 5 and 13 completed three experimental paradigms. They were asked...

Cite
Stolarova M, Brielmann AA. Does anyone need help? Age and gender effects on children's ability to recognize need-of-help. Front Psychol. 2014;5:170doi: 10.3389/fpsyg.2014.00170.
Stolarova, M., & Brielmann, A. A. (2014). Does anyone need help? Age and gender effects on children's ability to recognize need-of-help. Frontiers in psychology, 5170. https://doi.org/10.3389/fpsyg.2014.00170
Stolarova, Margarita, and Brielmann, Aenne A. "Does anyone need help? Age and gender effects on children's ability to recognize need-of-help." Frontiers in psychology vol. 5 (2014): 170. doi: https://doi.org/10.3389/fpsyg.2014.00170
Stolarova M, Brielmann AA. Does anyone need help? Age and gender effects on children's ability to recognize need-of-help. Front Psychol. 2014 Feb 27;5:170. doi: 10.3389/fpsyg.2014.00170. eCollection 2014. PMID: 24578698; PMCID: PMC3936112.
Copy Download .nbib Format: NLM
The pattern of physical comorbidity and the psychosocial determinants of depression: a prospective cohort study on a representative sample of family practice attendees in Slovenia.

Mental health in family medicine

Selič P, Svab I, Rifel J, Pavlič DR, Cerne A, King M, Nazareth I.
PMID: 22942896
Ment Health Fam Med. 2011 Sep;8(3):147-55.

Objectives This study aims to present the patterns of physical comorbidity in depressed patients and factors strongly associated with depression in a representative sample of Slovenian family practice attendees.Methods Medical data was obtained for 911 general practice attendees. Of...

Cite
Selič P, Svab I, Rifel J, et al. The pattern of physical comorbidity and the psychosocial determinants of depression: a prospective cohort study on a representative sample of family practice attendees in Slovenia. Ment Health Fam Med. 2011;8(3):147-55
Selič, P., Svab, I., Rifel, J., Pavlič, D. R., Cerne, A., King, M., & Nazareth, I. (2011). The pattern of physical comorbidity and the psychosocial determinants of depression: a prospective cohort study on a representative sample of family practice attendees in Slovenia. Mental health in family medicine, 8(3), 147-55.
Selič, Polona, et al. "The pattern of physical comorbidity and the psychosocial determinants of depression: a prospective cohort study on a representative sample of family practice attendees in Slovenia." Mental health in family medicine vol. 8,3 (2011): 147-55.
Selič P, Svab I, Rifel J, Pavlič DR, Cerne A, King M, Nazareth I. The pattern of physical comorbidity and the psychosocial determinants of depression: a prospective cohort study on a representative sample of family practice attendees in Slovenia. Ment Health Fam Med. 2011 Sep;8(3):147-55. PMID: 22942896; PMCID: PMC3314271.
Copy Download .nbib Format: NLM
Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.

Intensive care medicine

Alhazzani W, Alshamsi F, Belley-Cote E, Heels-Ansdell D, Brignardello-Petersen R, Alquraini M, Perner A, Møller MH, Krag M, Almenawer S, Rochwerg B, Dionne J, Jaeschke R, Alshahrani M, Deane A, Perri D, Thebane L, Al-Omari A, Finfer S, Cook D, Guyatt G.
PMID: 29230521
Intensive Care Med. 2018 Feb;44(2):277-278. doi: 10.1007/s00134-017-5023-6.

Owing to an oversight by the authors, all the figures in the last column of Table 2 (upper section: Number needed to treat; lower section: Number needed to harm) in this article were given without the final digit 0...

Cite
Alhazzani W, Alshamsi F, Belley-Cote E, et al. Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med. 2018;44(2):277-278doi: 10.1007/s00134-017-5023-6.
Alhazzani, W., Alshamsi, F., Belley-Cote, E., Heels-Ansdell, D., Brignardello-Petersen, R., Alquraini, M., Perner, A., Møller, M. H., Krag, M., Almenawer, S., Rochwerg, B., Dionne, J., Jaeschke, R., Alshahrani, M., Deane, A., Perri, D., Thebane, L., Al-Omari, A., Finfer, S., Cook, D., & Guyatt, G. (2018). Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive care medicine, 44(2), 277-278. https://doi.org/10.1007/s00134-017-5023-6
Alhazzani, Waleed, et al. "Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials." Intensive care medicine vol. 44,2 (2018): 277-278. doi: https://doi.org/10.1007/s00134-017-5023-6
Alhazzani W, Alshamsi F, Belley-Cote E, Heels-Ansdell D, Brignardello-Petersen R, Alquraini M, Perner A, Møller MH, Krag M, Almenawer S, Rochwerg B, Dionne J, Jaeschke R, Alshahrani M, Deane A, Perri D, Thebane L, Al-Omari A, Finfer S, Cook D, Guyatt G. Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med. 2018 Feb;44(2):277-278. doi: 10.1007/s00134-017-5023-6. PMID: 29230521; PMCID: PMC6828280.
Copy Download .nbib Format: NLM
Promising role of drug-coated balloons in the tibial vessels?.

The Journal of cardiovascular surgery

Langhoff R, Behne A, Buschmann EE.
PMID: 27332681
J Cardiovasc Surg (Torino). 2016 Jun 22; Epub 2016 Jun 22.

To judge on the role of drug-coated balloons (DCB) in below-the-knee (BTK) artery interventions, we analyzed randomized trials which compare coated to non-coated balloons and additionally a direct comparison of drug-eluting stents (DES) with DCB. As angioplasty with non-coated...

Cite
Langhoff R, Behne A, Buschmann EE. Promising role of drug-coated balloons in the tibial vessels?. J Cardiovasc Surg (Torino). 2016;
Langhoff, R., Behne, A., & Buschmann, E. E. (2016). Promising role of drug-coated balloons in the tibial vessels?. The Journal of cardiovascular surgery, .
Langhoff, Ralf, et al. "Promising role of drug-coated balloons in the tibial vessels?." The Journal of cardiovascular surgery vol. (2016).
Langhoff R, Behne A, Buschmann EE. Promising role of drug-coated balloons in the tibial vessels?. J Cardiovasc Surg (Torino). 2016 Jun 22; Epub 2016 Jun 22. PMID: 27332681.
Copy Download .nbib Format: NLM
Bone Mineral Is More Heterogeneously Distributed in the Femoral Heads of Osteoporotic and Diabetic Patients: A Pilot Study.

JBMR plus

Parle E, Tio S, Behre A, Carey JJ, Murphy CG, O'Brien TF, Curtin WA, Kearns SR, McCabe JP, Coleman CM, Vaughan TJ, McNamara LM.
PMID: 32149268
JBMR Plus. 2019 Dec 11;4(2):e10253. doi: 10.1002/jbm4.10253. eCollection 2020 Feb.

Osteoporosis is associated with systemic bone loss, leading to a significant deterioration of bone microarchitecture and an increased fracture risk. Although recent studies have shown that the distribution of bone mineral becomes more heterogeneous because of estrogen deficiency in...

Cite
Parle E, Tio S, Behre A, et al. Bone Mineral Is More Heterogeneously Distributed in the Femoral Heads of Osteoporotic and Diabetic Patients: A Pilot Study. JBMR Plus. 2019;4(2):e10253doi: 10.1002/jbm4.10253.
Parle, E., Tio, S., Behre, A., Carey, J. J., Murphy, C. G., O'Brien, T. F., Curtin, W. A., Kearns, S. R., McCabe, J. P., Coleman, C. M., Vaughan, T. J., & McNamara, L. M. (2020). Bone Mineral Is More Heterogeneously Distributed in the Femoral Heads of Osteoporotic and Diabetic Patients: A Pilot Study. JBMR plus, 4(2), e10253. https://doi.org/10.1002/jbm4.10253
Parle, Eoin, et al. "Bone Mineral Is More Heterogeneously Distributed in the Femoral Heads of Osteoporotic and Diabetic Patients: A Pilot Study." JBMR plus vol. 4,2 (2020): e10253. doi: https://doi.org/10.1002/jbm4.10253
Parle E, Tio S, Behre A, Carey JJ, Murphy CG, O'Brien TF, Curtin WA, Kearns SR, McCabe JP, Coleman CM, Vaughan TJ, McNamara LM. Bone Mineral Is More Heterogeneously Distributed in the Femoral Heads of Osteoporotic and Diabetic Patients: A Pilot Study. JBMR Plus. 2019 Dec 11;4(2):e10253. doi: 10.1002/jbm4.10253. eCollection 2020 Feb. PMID: 32149268; PMCID: PMC7017882.
Copy Download .nbib Format: NLM
Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer.

mAbs

Xiang H, Chan AG, Ahene A, Bellovin DI, Deng R, Hsu AW, Jeffry U, Palencia S, Powers J, Zanghi J, Collins H.
PMID: 34719330
MAbs. 2021 Jan-Dec;13(1):1981202. doi: 10.1080/19420862.2021.1981202.

Bemarituzumab (FPA144) is a first-in-class, humanized, afucosylated immunoglobulin G1 monoclonal antibody (mAb) directed against fibroblast growth factor receptor 2b (FGFR2b) with two mechanisms of action against FGFR2b-overexpressing tumors: inhibition of FGFR2b signaling and enhanced antibody-dependent cell-mediated cytotoxicity (ADCC). Bemarituzumab...

Cite
Xiang H, Chan AG, Ahene A, et al. Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer. MAbs. 2021;13(1):1981202doi: 10.1080/19420862.2021.1981202.
Xiang, H., Chan, A. G., Ahene, A., Bellovin, D. I., Deng, R., Hsu, A. W., Jeffry, U., Palencia, S., Powers, J., Zanghi, J., & Collins, H. (2021). Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer. mAbs, 13(1), 1981202. https://doi.org/10.1080/19420862.2021.1981202
Xiang, Hong, et al. "Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer." mAbs vol. 13,1 (2021): 1981202. doi: https://doi.org/10.1080/19420862.2021.1981202
Xiang H, Chan AG, Ahene A, Bellovin DI, Deng R, Hsu AW, Jeffry U, Palencia S, Powers J, Zanghi J, Collins H. Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer. MAbs. 2021 Jan-Dec;13(1):1981202. doi: 10.1080/19420862.2021.1981202. PMID: 34719330; PMCID: PMC8565817.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 143 entries